{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:02:15Z","timestamp":1780333335820,"version":"3.54.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200164"],"award-info":[{"award-number":["82200164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.lrr.2025.100530","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T23:30:56Z","timestamp":1753313456000},"page":"100530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Thymic stromal lymphopoietin in leukemia: A double-edged sword?"],"prefix":"10.1016","volume":"24","author":[{"given":"Xing","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Gang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0001","first-page":"321","article-title":"A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells[J]","volume":"22","author":"Friend","year":"1994","journal-title":"Exp. Hematol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0002","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1165\/rcmb.2008-0041OC","article-title":"Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells[J]","volume":"40","author":"Harada","year":"2009","journal-title":"Am. J. Respir Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0003","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4049\/jimmunol.167.1.336","article-title":"Human thymic stromal lymphopoietin preferentially stimulates myeloid cells[J]","volume":"167","author":"Reche","year":"2001","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.lrr.2025.100530_bib0004","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/jid.2014.83","article-title":"TNF-\u03b1 and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents[J]","volume":"134","author":"Danso","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.lrr.2025.100530_bib0005","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.179.2.1080","article-title":"TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells[J]","volume":"179","author":"Kato","year":"2007","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.lrr.2025.100530_bib0006","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1167\/iovs.08-3074","article-title":"Human corneal epithelium-derived thymic stromal lymphopoietin links the innate and adaptive immune responses via TLRs and Th2 cytokines[J]","volume":"50","author":"Ma","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.lrr.2025.100530_bib0007","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch[J]","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lrr.2025.100530_bib0008","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2015.04.047","article-title":"IL-33 and Thymic Stromal lymphopoietin in mast cell functions[J]","volume":"778","author":"Saluja","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0009","doi-asserted-by":"crossref","first-page":"L479","DOI":"10.1152\/ajplung.00301.2009","article-title":"Essential role of NF-\u03bab and AP-1 transcription factors in TNF-\u03b1-induced TSLP expression in human airway smooth muscle cells[J]","volume":"300","author":"Redhu","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40425-019-0521-4","article-title":"The IL-1\/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer[J]","volume":"7","author":"Brunetto","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.lrr.2025.100530_bib0011","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2009-11-252940","article-title":"Thymic stromal lymphopoietin from trophoblasts induces dendritic cell-mediated regulatory TH2 bias in the decidua during early gestation in humans[J]","volume":"116","author":"Guo","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2019.09.004","article-title":"Staphylococcus aureus lipoteichoic acid initiates a TSLP-basophil-IL4 axis in the skin[J]","volume":"140","author":"Brauweiler","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.lrr.2025.100530_bib0013","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdermsci.2011.02.012","article-title":"Secretion of thymic stromal lymphopoietin from human keratinocytes in response to Malassezia yeasts[J]","volume":"62","author":"Ishibashi","year":"2011","journal-title":"J. Dermatol. Sci."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0014","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1164\/rccm.201710-2112OC","article-title":"Staphylococcus aureus induces a mucosal type 2 immune response via epithelial cell-derived cytokines[J]","volume":"198","author":"Lan","year":"2018","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"10.1016\/j.lrr.2025.100530_bib0015","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.3389\/fimmu.2019.02152","article-title":"Host components contributing to Respiratory syncytial virus pathogenesis[J]","volume":"10","author":"Carvajal","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0016","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41385-019-0171-3","article-title":"Sex-associated TSLP-induced immune alterations following early-life RSV infection leads to enhanced allergic disease[J]","volume":"12","author":"Malinczak","year":"2019","journal-title":"Mucosal. Immunol."},{"key":"10.1016\/j.lrr.2025.100530_bib0017","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3389\/fimmu.2019.01154","article-title":"Cytokines in the Respiratory airway as biomarkers of severity and prognosis for Respiratory syncytial virus infection: an update[J]","volume":"10","author":"V\u00e1zquez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lrr.2025.100530_bib0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.12659\/MSMBR.889791","article-title":"Plasmacytoid DCs, exposed to TSLP in synergy with TLR ligands, acquire significant potential towards Th2 polarization[J]","volume":"19","author":"Kopecka","year":"2013","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.lrr.2025.100530_bib0019","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/B978-0-12-397925-4.00021-3","article-title":"TSLP expression induced via toll-like receptor pathways in human keratinocytes[J]","volume":"535","author":"Takai","year":"2014","journal-title":"Methods Enzymol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jdermsci.2012.03.007","article-title":"Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes[J]","volume":"66","author":"Xie","year":"2012","journal-title":"J. Dermatol. Sci."},{"issue":"33","key":"10.1016\/j.lrr.2025.100530_bib0021","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.1073\/pnas.0906367106","article-title":"Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating dendritic cell function[J]","volume":"106","author":"Massacand","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"8","key":"10.1016\/j.lrr.2025.100530_bib0022","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.1800709","article-title":"Bronchial allergen challenge of patients with atopic asthma triggers an alarmin (IL-33, TSLP, and IL-25) response in the Airways epithelium and submucosa[J]","volume":"201","author":"Wang","year":"2018","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.lrr.2025.100530_bib0023","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20062211","article-title":"Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells[J]","volume":"204","author":"Allakhverdi","year":"2007","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.lrr.2025.100530_bib0024","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.4049\/jimmunol.178.6.3373","article-title":"Cutting edge: proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes[J]","volume":"178","author":"Bogiatzi","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1073\/pnas.0607305104","article-title":"Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB[J]","volume":"104","author":"Lee","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"41","key":"10.1016\/j.lrr.2025.100530_bib0026","doi-asserted-by":"crossref","first-page":"14795","DOI":"10.1073\/pnas.0507385102","article-title":"Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin[J]","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"31","key":"10.1016\/j.lrr.2025.100530_bib0027","doi-asserted-by":"crossref","first-page":"11736","DOI":"10.1073\/pnas.0604575103","article-title":"Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis[J]","volume":"103","author":"Li","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"8","key":"10.1016\/j.lrr.2025.100530_bib0028","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.4049\/jimmunol.181.8.5189","article-title":"Cutting edge: inhibition of NF-kappaB-mediated TSLP expression by retinoid X receptor[J]","volume":"181","author":"Lee","year":"2008","journal-title":"J. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.lrr.2025.100530_bib0029","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbrc.2022.05.095","article-title":"Targeting circNCLN\/miR-291a-3p\/TSLP signaling axis alleviates lipopolysaccharide-induced acute lung injury[J]","volume":"617","author":"Cao","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.61.3.8","article-title":"The potential inhibitory effects of miR-19b on ocular inflammation are mediated upstream of the JAK\/STAT pathway in a murine model of allergic conjunctivitis[J]","volume":"61","author":"Guo","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0031","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1038\/s41598-023-34418-y","article-title":"Exosomes with overexpressed miR 147a suppress angiogenesis and infammatory injury in an experimental model of atopic dermatitis[J]","volume":"13","author":"Shi","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.lrr.2025.100530_bib0032","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4049\/jimmunol.162.2.677","article-title":"Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism[J]","volume":"162","author":"Levin","year":"1999","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0033","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/eji.1830260103","article-title":"Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro[J]","volume":"26","author":"Ray","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.lrr.2025.100530_bib0034","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.20050199","article-title":"A role for TSLP in the development of inflammation in an asthma model[J]","volume":"202","author":"Al-Shami","year":"2005","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.lrr.2025.100530_bib0035","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ni1247","article-title":"Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice[J]","volume":"6","author":"Zhou","year":"2005","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0036","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.20041503","article-title":"Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin[J]","volume":"202","author":"Yoo","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0037","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/ced.12206","article-title":"Promoter demethylation contributes to TSLP overexpression in skin lesions of patients with atopic dermatitis[J]","volume":"39","author":"Luo","year":"2014","journal-title":"Clin. Exp. Dermatol."},{"issue":"11","key":"10.1016\/j.lrr.2025.100530_bib0038","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial[J]","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0039","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1038\/s41598-021-86179-1","article-title":"Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma[J]","volume":"11","author":"Ko","year":"2021","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.lrr.2025.100530_bib0040","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1136\/annrheumdis-2012-202279","article-title":"A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis[J]","volume":"72","author":"Usategui","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lrr.2025.100530_bib0041","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4594630","article-title":"Thymic stromal lymphopoietin is implicated in the pathogenesis of bullous pemphigoid by dendritic cells[J]","volume":"2020","author":"Li","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.lrr.2025.100530_bib0042","article-title":"Increased expression of long-isoform thymic stromal lymphopoietin is associated with rheumatoid arthritis and fosters inflammatory responses[J]","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0043","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","article-title":"Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer[J]","volume":"208","author":"De Monte","year":"2011","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.lrr.2025.100530_bib0044","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.4049\/jimmunol.1100463","article-title":"Thymic stromal lymphopoietin is a key mediator of breast cancer progression[J]","volume":"186","author":"Olkhanud","year":"2011","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.lrr.2025.100530_bib0045","first-page":"7483","article-title":"TSLP promotes angiogenesis of human umbilical vein endothelial cells by strengthening the crosstalk between cervical cancer cells and eosinophils[J]","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0046","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00262-020-02488-w","article-title":"The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma[J]","volume":"69","author":"Lin","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0047","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41388-020-01567-7","article-title":"RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia[J]","volume":"40","author":"Koschut","year":"2021","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.lrr.2025.100530_bib0048","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1084\/jem.192.5.659","article-title":"Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor[J]","volume":"192","author":"Park","year":"2000","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0049","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00018-013-1337-x","article-title":"Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia[J]","volume":"71","author":"Tal","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.lrr.2025.100530_bib0050","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3389\/fimmu.2020.01557","article-title":"Modulation of signaling mediated by TSLP and IL-7 in inflammation, autoimmune diseases, and cancer[J]","volume":"11","author":"Markovi\u0107","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0051","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2016.09.014","article-title":"Insight into the role of TSLP in inflammatory bowel diseases[J]","volume":"16","author":"Park","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lrr.2025.100530_bib0052","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3389\/fimmu.2018.01775","article-title":"Genetic regulation of the thymic stromal lymphopoietin (TSLP)\/TSLP receptor (TSLPR) gene expression and influence of epistatic interactions between IL-33 and the TSLP\/TSLPR axis on risk of coronary artery disease[J]","volume":"9","author":"Nie","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lrr.2025.100530_bib0053","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/bjh.18531","article-title":"Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease[J]","volume":"200","author":"Fu","year":"2023","journal-title":"Br J. Haematol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.05.010","article-title":"A thymic stromal lymphopoietin-responsive dendritic cell subset mediates allergic responses in the upper airway mucosa[J]","volume":"134","author":"Melum","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41590-018-0066-6","article-title":"A tumor-myeloid cell axis, mediated via the cytokines IL-1\u03b1 and TSLP, promotes the progression of breast cancer[J]","volume":"19","author":"Kuan","year":"2018","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0056","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1172\/JCI83724","article-title":"Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis[J]","volume":"126","author":"Demehri","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.lrr.2025.100530_bib0057","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1178438","article-title":"No evidence for TSLP pathway activity in human breast cancer[J]","volume":"5","author":"Ghirelli","year":"2016","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.lrr.2025.100530_bib0058","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12098-015-1695-5","article-title":"Leukemias in children[J]","volume":"82","author":"Seth","year":"2015","journal-title":"Indian J. Pediatr."},{"issue":"6","key":"10.1016\/j.lrr.2025.100530_bib0059","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update[J]","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J."},{"issue":"17","key":"10.1016\/j.lrr.2025.100530_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173792","article-title":"Biologic and therapeutic implications of genomic alterations in acute lymphoblastic leukemia[J]","volume":"10","author":"Iacobucci","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.lrr.2025.100530_bib0061","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ni1452","article-title":"Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development[J]","volume":"8","author":"Astrakhan","year":"2007","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0062","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-0041-1742246","article-title":"Genetic profiling of pediatric patients with B-cell precursor acute lymphoblastic leukemia[J]","volume":"12","author":"Akin-Bali","year":"2023","journal-title":"J. Pediatr. Genet."},{"issue":"2","key":"10.1016\/j.lrr.2025.100530_bib0063","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/10428194.2020.1832668","article-title":"Combined analysis of IKZF1 deletions and CRLF2 expression on prognostic impact in pediatric B-cell precursor acute lymphoblastic leukemia[J]","volume":"62","author":"Cui","year":"2021","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.lrr.2025.100530_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1256054","article-title":"Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes[J]","volume":"13","author":"Lin","year":"2023","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/10428194.2022.2164193","article-title":"The prognostic significance of CRLF2 expression at diagnosis in adult ph-negative B-cell precursor acute lymphoblastic leukemia[J]","volume":"64","author":"Wang","year":"2023","journal-title":"Leuk Lymphoma."},{"issue":"6","key":"10.1016\/j.lrr.2025.100530_bib0066","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3324\/haematol.2020.247973","article-title":"Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913[J]","volume":"106","author":"Chiaretti","year":"2021","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.lrr.2025.100530_bib0067","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia[J]","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.lrr.2025.100530_bib0068","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood-2009-08-235408","article-title":"Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group[J]","volume":"115","author":"Hertzberg","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0069","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOH.0000000000000050","article-title":"Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises[J]","volume":"21","author":"Izraeli","year":"2014","journal-title":"Curr. Opin Hematol."},{"issue":"2","key":"10.1016\/j.lrr.2025.100530_bib0070","first-page":"172","article-title":"Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia[J]","volume":"142","author":"Li","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0071","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/blood-2013-06-509463","article-title":"Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group[J]","volume":"123","author":"Buitenkamp","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.lrr.2025.100530_bib0072","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41388-021-02126-4","article-title":"HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort[J]","volume":"41","author":"Page","year":"2022","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.lrr.2025.100530_bib0073","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20110580","article-title":"Gain-of-function mutations in interleukin-7 receptor-\u03b1 (IL7R) in childhood acute lymphoblastic leukemias[J]","volume":"208","author":"Shochat","year":"2011","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.lrr.2025.100530_bib0074","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/ng.924","article-title":"Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia[J]","volume":"43","author":"Zenatti","year":"2011","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0075","first-page":"1058","article-title":"Clinical significance of CRLF2 high expression in bone marrow mononuclear cells from children with acute lymphoblastic leukemia] [J]","volume":"27","author":"Kuang","year":"2019","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"37","key":"10.1016\/j.lrr.2025.100530_bib0076","doi-asserted-by":"crossref","first-page":"59260","DOI":"10.18632\/oncotarget.10610","article-title":"CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia[J]","volume":"7","author":"Palmi","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.lrr.2025.100530_bib0077","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/gcc.23036","article-title":"CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia[J]","volume":"61","author":"Maciel","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.lrr.2025.100530_bib0078","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/gcc.22723","article-title":"CRLF2 expression associates with ICN1 stabilization in T-cell acute lymphoblastic leukemia[J]","volume":"58","author":"Maciel","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"25","key":"10.1016\/j.lrr.2025.100530_bib0079","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2016-12-758979","article-title":"Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group[J]","volume":"129","author":"Reshmi","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.lrr.2025.100530_bib0080","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia[J]","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.lrr.2025.100530_bib0081","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ijlh.13419","article-title":"Effects of different aberrations in the CRLF2 gene on the biological characteristics and drug sensitivities of Nalm6 cells[J]","volume":"43","author":"Gu","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"2","key":"10.1016\/j.lrr.2025.100530_bib0082","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41588-021-00993-x","article-title":"Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation[J]","volume":"54","author":"Yang","year":"2022","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.lrr.2025.100530_bib0083","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc1362","article-title":"The TOR pathway: a target for cancer therapy[J]","volume":"4","author":"Bjornsti","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.lrr.2025.100530_bib0084","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship[J]","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer[J]","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lrr.2025.100530_bib0086","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exphem.2022.03.005","article-title":"CRLF2 overexpression results in reduced B-cell differentiation and upregulated E2F signaling in the Dp16 mouse model of Down syndrome[J]","volume":"110","author":"Junco","year":"2022","journal-title":"Exp. Hematol."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0087","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","article-title":"Aberrant STAT5 and PI3K\/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia[J]","volume":"120","author":"Tasian","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0088","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3324\/haematol.2015.125336","article-title":"A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis[J]","volume":"101","author":"Francis","year":"2016","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.lrr.2025.100530_bib0089","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1182\/blood-2012-02-413252","article-title":"Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2[J]","volume":"120","author":"Van Bodegom","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.lrr.2025.100530_bib0090","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1158\/1541-7786.MCR-19-1098","article-title":"Targeting TSLP-induced tyrosine kinase signaling pathways in CRLF2-rearranged ph-like ALL[J]","volume":"18","author":"Sia","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lrr.2025.100530_bib0091","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.leukres.2015.10.003","article-title":"Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients[J]","volume":"40","author":"Vetter","year":"2016","journal-title":"Leuk Res."},{"issue":"5","key":"10.1016\/j.lrr.2025.100530_bib0092","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood-2014-11-612903","article-title":"Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein[J]","volume":"126","author":"Qin","year":"2015","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.lrr.2025.100530_bib0093","doi-asserted-by":"crossref","first-page":"E4030","DOI":"10.1073\/pnas.1702489114","article-title":"Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome[J]","volume":"114","author":"Schwartzman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"11","key":"10.1016\/j.lrr.2025.100530_bib0094","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41375-021-01248-8","article-title":"Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia[J]","volume":"35","author":"B\u04e7hm","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2025.100530_bib0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijbiomac.2021.08.194","article-title":"A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia[J]","volume":"190","author":"Mohamed","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.lrr.2025.100530_bib0096","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/s41375-023-02010-y","article-title":"Preclinical development of 1B7\/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged ph-like B-ALL[J]","volume":"37","author":"Tian","year":"2023","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.lrr.2025.100530_bib0097","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1172\/JCI134424","article-title":"Oncogene-independent BCR-like signaling adaptation confers drug resistance in ph-like ALL[J]","volume":"130","author":"Hurtz","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.lrr.2025.100530_bib0098","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.2021012976","article-title":"Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged ph-like ALL[J]","volume":"139","author":"Sasaki","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.lrr.2025.100530_bib0099","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220026","article-title":"CRLF2 rearrangement in ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition[J]","volume":"14","author":"Meyer","year":"2019","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.lrr.2025.100530_bib0100","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-16-0992","article-title":"Thymic stromal chemokine TSLP acts through Th2 cytokine production to induce cutaneous T-cell lymphoma[J]","volume":"76","author":"Takahashi","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0101","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccr.2012.08.016","article-title":"Loss of cutaneous TSLP-dependent immune responses skews the balance of inflammation from tumor protective to tumor promoting[J]","volume":"22","author":"Di Piazza","year":"2012","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.lrr.2025.100530_bib0102","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ccr.2012.08.017","article-title":"Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin[J]","volume":"22","author":"Demehri","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.lrr.2025.100530_bib0103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010474","article-title":"TSLP as a potential therapy in the treatment of CRLF2 B cell acute lymphoblastic leukemia[J]","volume":"24","author":"Alkashgari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.lrr.2025.100530_bib0104","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/eji.201646307","article-title":"TSLP or IL-7 provide an IL-7R\u03b1 signal that is critical for human B lymphopoiesis[J]","volume":"46","author":"Milford","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"13","key":"10.1016\/j.lrr.2025.100530_bib0105","doi-asserted-by":"crossref","first-page":"16840","DOI":"10.18632\/oncotarget.7614","article-title":"Thymic stromal lymphopoietin (TSLP) inhibits human colon tumor growth by promoting apoptosis of tumor cells[J]","volume":"7","author":"Yue","year":"2016","journal-title":"Oncotarget"},{"issue":"2 Pt 2","key":"10.1016\/j.lrr.2025.100530_bib0106","first-page":"e457","article-title":"Increased serum thymic stromal lymphopoietin in children with atopic dermatitis[J]","volume":"21","author":"Lee","year":"2010","journal-title":"Pediatr. Allergy Immunol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:46:42Z","timestamp":1764852402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048925000329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":106,"alternative-id":["S2213048925000329"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100530","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymic stromal lymphopoietin in leukemia: A double-edged sword?","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100530"}}